Clinical Trial Update: Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether sodium thiosulfate reduces nephrotoxicity from intraperitoneal cisplatin during heat-perfusion chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Kidney Injury Due to Circulatory Failure

Drugs mentioned

• CISPLATIN (cisplatin)
• Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure | Phase 2 | Status: UNKNOWN